John Rondoni, Chief Technology Officer at Inspire Medical Systems, Inc. (INSP), sold 17,078 shares at $179.26 ($3.1M) on 2024-02-29, disclosed to the SEC on 2024-03-04.
Scheduled sale ($3.1M) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.23 | 6,218 | $1.1M | 36.4% |
| 2 | $179.23 | 6,218 | $1.1M | 36.4% |
| 3 | $179.26 | 2,255 | $404K | 13.2% |
| 4 | $179.26 | 2,255 | $404K | 13.2% |
| 5 | $179.98 | 52 | $9K | 0.3% |
| 6 | $179.98 | 80 |
| $14K |
| 0.5% |
| Total | $179.24 avg | 17,078 | $3.1M | 100% |
| Filing → |
| INSP | SELL | 2026-01-12 | $11K | — | Filing → |
| INSP | SELL | 2025-05-21 | $518K | — | Filing → |
| INSP | SELL | 2025-03-05 | $849K | — | Filing → |